Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 406938
Gene Symbol: MIR146A
MIR146A
0.100 AlteredExpression disease BEFREE Moreover, in obese BC patients, a significant increase in both miR-21 and miR-146a expression is revealed in cases with lymph node metastasis. 30303554 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.100 AlteredExpression disease BEFREE Besides, the high expression levels of serum Hcy, VEGF, and G17 had evident correlations with the tumor-node-metastasis (TNM) stage, Lauren type, infiltration depth, and lymph node metastasis of gastric cancer (p<0.05). 31173290 2019
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.100 Biomarker disease BEFREE Lymph node metastases and a high baseline prostate-specific antigen (PSA) were independent predictors of early treatment discontinuation. 31802949 2019
Entrez Id: 652995
Gene Symbol: UCA1
UCA1
0.100 AlteredExpression disease BEFREE In silico analysis showed that <i>FAM95B1</i> and <i>UCA1</i> were significantly correlated with cervical lymph node metastasis, tumor staging, and PTC prognosis (<i>P</i><0.05). qRT-PCR analysis revealed high UCA1 expression in PTC tissues and correlations between UCA1 expression levels and cervical lymph node metastasis and tumor staging in PTC, that is, higher <i>UCA1</i> expression resulted in poorer PTC prognosis. 30863094 2019
Entrez Id: 5728
Gene Symbol: PTEN
PTEN
0.100 Biomarker disease BEFREE PTEN-deficient lymph node metastasis had a distinct profile, with high levels of CD8+ T cells. 30999388 2019
Entrez Id: 3732
Gene Symbol: CD82
CD82
0.100 AlteredExpression disease BEFREE Low expression of KAI1 might be helpful for predicting the lymph node metastasis and T staging, thus predicts malignant prognosis of breast cancer.<br />. 31759355 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.100 Biomarker disease BEFREE Impact of Neoadjuvant Chemotherapy on Concordance of PD-L1 Staining Fidelity between the Primary Tumor and Lymph Node Metastases in Bladder Cancer. 31201825 2019
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE Immunohistochemical staining revealed that DKK-3 was positively linked to but β-catenin and c-MYC were negatively linked to differentiation, tumor-node-metastasis (TNM) stage and lymph node metastasis of patients with NPC. 31025872 2019
Entrez Id: 406971
Gene Symbol: MIR195
MIR195
0.100 Biomarker disease BEFREE Patients with a high hsa_circ_006100 level or low miR-195 level had tumours with a high TNM stage, poor cellular differentiation and lymph node metastasis. miR-195 was targeted and inhibited by hsa_circ_006100. 31318114 2019
Entrez Id: 406938
Gene Symbol: MIR146A
MIR146A
0.100 AlteredExpression disease BEFREE A dramatic overexpression of miR-146a was observed in primary gastric tumors. miR-146a showed lower expression in progressed tumors with greater stages and lymph node metastasis. 30880764 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.100 AlteredExpression disease BEFREE PD-L1 expression was significantly associated with lymph node metastasis (P < .001), high tumor grade (P < .001), negative hormone receptor (P < .001), human epidermal growth factor receptor 2 (HER2) positivity (P < .001), high Ki67 (P < .001), and high tumor-infiltrating lymphocytes (TILs) (P < .001). 31008945 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.100 AlteredExpression disease BEFREE Patients with high PD-L1 expression were more likely to exhibit adverse pathologic features including an advanced T stage (<i>P</i> = 0.002) and lymph node metastasis (<i>P</i> = 0.044). 31824835 2019
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.100 AlteredExpression disease BEFREE The median prostate-specific antigen level at imaging and number of LNM per patient were significantly higher in the <sup>18</sup>F-choline group (3.4 ng/mL, <i>n</i> = 34) than in the <sup>68</sup>Ga-PSMA group (2.2 ng/mL, <i>n</i> = 28; both <i>P</i> < 0.05). 30683768 2019
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.100 AlteredExpression disease BEFREE We evaluate CD274 (PD-L1), CDKN2A (p16), tumor protein p53 (TP53), and epidermal growth factor receptor (EGFR) immunoexpression in primary tumors, recurrences and lymph node metastases and its correlations with prognosis and HPV status. 31844270 2019
Entrez Id: 4318
Gene Symbol: MMP9
MMP9
0.100 AlteredExpression disease BEFREE The aim of this study was to investigate the expression of MMP-9 and VEGF-C at both mRNA and protein levels in breast cancer and to correlate with lymph node metastasis and other clinicopathological characteristics. 30993496 2019
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.100 Biomarker disease BEFREE Predictive value of computed tomography in identifying extracapsular spread of cervical lymph node metastases in p16 positive oropharyngeal squamous cell carcinoma. 30973213 2019
Entrez Id: 7852
Gene Symbol: CXCR4
CXCR4
0.100 Biomarker disease BEFREE The present study investigated lymph node metastasis in the light of PDCs infiltration and the potential cross talk with CXCR4/SDF-1 chemokine axis. 30632021 2019
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.100 Biomarker disease BEFREE SPDEF positivity was significantly associated with tumour stage, Gleason grade, lymph node metastasis and PSA recurrence (all P<0.0001). 31612022 2019
Entrez Id: 6657
Gene Symbol: SOX2
SOX2
0.100 Biomarker disease BEFREE In the present study, SOX2 was positively associated with NSCLC stage and lymph node metastasis. 31316613 2019
Entrez Id: 673
Gene Symbol: BRAF
BRAF
0.100 Biomarker disease BEFREE Kruskal-Wallis test was used for the univariate correlation analyses and comparison of mutation rate and expression rate, and Chi-square test was used for the association of central lymph node metastasis with BRAF gene and TSHR. 30655754 2019
Entrez Id: 1048
Gene Symbol: CEACAM5
CEACAM5
0.100 GeneticVariation disease BEFREE Parenchymal-type MF-iCCA (21/78, 27%) exhibited significantly lower serum carbohydrate antigen 19-9 (12.8 vs. 173.8 U/mL) and carcinoembryonic antigen (1.7 vs. 4.2 ng/mL), more frequent viral hepatitis (43% vs. 18%), less frequent biliary intraepithelial neoplasia (0% vs. 26%), and less frequent perineural invasion (0% vs. 59%) and lymph node metastasis (7% vs. 46%), compared with the ductal type (57/78, 73%) (p < 0.05 for all). 30560357 2019
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 AlteredExpression disease BEFREE GC patients with greater invasion depth (P = .007), higher pathological TNM stage (P = .014), and lymph node metastasis (P = .026) showed lower LKB1 expression; furthermore, E-cadherin and β-catenin expression decreased, whereas vimentin expression increased (all P < .05). 30171989 2019
Entrez Id: 1499
Gene Symbol: CTNNB1
CTNNB1
0.100 Biomarker disease BEFREE Fibulin-2 and β-catenin had a negative correlation (r=-0.361, P=0.003), but was closely correlated with the tumor size and lymph node metastasis (P<0.05). 31452758 2019
Entrez Id: 11186
Gene Symbol: RASSF1
RASSF1
0.100 Biomarker disease BEFREE Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation. 31638213 2019
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.100 AlteredExpression disease BEFREE Meta-analysis was performed to investigate the association between the PD-L1 expression either overall survival (OS), disease-free survival (DFS), disease-specific survival (DSS), gender and lymph node metastasis. 30443950 2019